After the vaccine of two companies in the war against the Coronavirus has been approved for emergency use, it may be difficult for the vaccine companies standing in front lines to be tested. There may be a problem with getting volunteers for their vaccines. It is known that on January 3 of this year, DCGI approved the Oxford Vaccine and indigenous Covaxin made at Serum Institute. Companies say recruitment has been adversely affected due to the news of the early availability of the vaccine.
Dr. V Krishna Mohan of Bharat Biotech said in a webinar, "There are several press releases without getting approval for emergency use, saying that their vaccine will be available soon." This is going to cause a lot of difficulty in recruitment, because most people are thinking about whether they should take part in clinical trials or not. After all, the vaccine is going to come soon. " Trials are taking place at the same time when the work of approving vaccines for emergency use is also going on in the country.
'Big challenge for India biotech'
He said that the challenge for Bharat Biotech was huge, as they were focusing on the older age group. He said that the oldest person to enroll for the covariate trial was 97. Mohan said, "Hospitals have also asked us whether it is morally right to continue clinical trials even when you have received emergency use. These questions should be answered. "Let us know that at least six human trials of corona vaccines are going on in the country. This is Zydus Cadila, which has recently started a third phase trial. Russia has Sputnik 5, whose second and third phase trials are being conducted by Dr. Reddy.
There is also an ongoing trial of these vaccines
Serum Institute of India also has the second vaccine Novavax, which is undergoing Phase II trials. Biological E and Genova are testing the first phase of their vaccine. Apart from this, work is also underway on another biotech vaccine of Bharat Biotech. Cadila Healthcare Chairperson Dr. Pankaj Patel also believes that recruitment time is going to be very challenging. He says the challenge will be to meet recruitment speed and volunteers. At the same time, there is also a concern that after the introduction of the vaccine, the weak people will get vaccinated soon.
The fall in the prices of cereals, wheat, onion, petrol, electricity, and minerals has brought re
Russian military action in Ukraine has worsened the situation. Meanwhile, the plane has reached D
Corbevax booster shot: Center approves the Corbevax vaccine as a booster dose
The Central Government has approved the Corbevax Booster Vaccine prepared by Biological E Company
Another Congress poster girl resigns in UP, Vandana with Shakti Vidhan told why she got angry
Another poster girl of Congress in Uttar Pradesh has given a big blow to the party. Party leader
Kejriwal government's gift before Diwali, big relief on outstanding water bills
There is good news for Delhiites. Ahead of Diwali, Chief Minister Arvind Kejriwal on Monday annou
COVID-19 Positive In Flight: An American woman was found to be Corona positive during air travel,
Prime Minister Narendra Modi held a bilateral meeting with Paraguay's President Santiago Pena Pal
The government said on Wednesday that telecom service providers have started providing 5G service
Bio Diversity: 60 percent of Asian countries behind 2020 biodiversity targets, Qatar did wonders
Most countries in Asia, including India, are lagging behind the biodiversity targets to be achiev
Renowned musician AR Rahman recently made a statement that has sparked considerable controversy.
